{
    "clinical_study": {
        "@rank": "62112", 
        "arm_group": [
            {
                "arm_group_label": "papaya 1% extract ointment", 
                "arm_group_type": "Experimental", 
                "description": "papaya 1% extract ointment twice a day for 1 week"
            }, 
            {
                "arm_group_label": "mupirocin 2% ointment", 
                "arm_group_type": "Active Comparator", 
                "description": "mupirocin 2% ointment twice a day for 1 week"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will be an investigator-blinded, patient-blinded, assessor-blinded,\n      parallel-group, randomized clinical trial. It aims to evaluate the efficacy of one-week\n      twice-daily application of topical papaya leaf extract ointment compared to mupirocin\n      ointment in achieving clinical cure among patients with impetigo."
        }, 
        "brief_title": "The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial", 
        "condition": "Impetigo", 
        "condition_browse": {
            "mesh_term": "Impetigo"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy Filipino patients aged 1 year and above with primary impetigo, limited to\n             less than or equal to 1% BSA, and involving only one body area\n\n        Exclusion Criteria:\n\n          -  Extensive impetigo (>1% BSA), affecting more than one body area\n\n          -  Systemic involvement (lymphadenopathy, fever, sepsis)\n\n          -  Chronic comorbidities like diabetes mellitus, malignancy, chronic venous\n             insufficiency\n\n          -  Concurrent immunosuppressive therapy\n\n          -  Patients \u2264 1 year\n\n          -  Pregnant & lactating patients"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "128", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01943136", 
            "org_study_id": "Papaya for impetigo"
        }, 
        "intervention": [
            {
                "arm_group_label": "papaya 1% extract ointment", 
                "intervention_name": "papaya 1% extract ointment", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "mupirocin 2% ointment", 
                "intervention_name": "mupirocin 2% ointment", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Mupirocin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "impetigo", 
            "papaya extract ointment"
        ], 
        "lastchanged_date": "December 18, 2013", 
        "location": {
            "contact": {
                "email": "janinequijanoMD@gmail.com", 
                "last_name": "Quijano"
            }, 
            "facility": {
                "address": {
                    "city": "Quezon City", 
                    "country": "Philippines", 
                    "state": "NCR"
                }, 
                "name": "St. Luke's Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Philippines"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "janinequijanoMD@gmail.com", 
            "last_name": "Janine L. Quijano, MD"
        }, 
        "overall_official": [
            {
                "affiliation": "St. Luke's Medical Center", 
                "last_name": "Mia Angela C Verzosa, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "St. Luke's Medical Center", 
                "last_name": "Pearl Weena Marie E Sabido, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "St. Luke's Medical Center", 
                "last_name": "Janine L. Quijano, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Philippines: Bureau of Food and Drugs"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Clinical clearance after 1 week of treatment", 
            "safety_issue": "No", 
            "time_frame": "1 week"
        }, 
        "reference": [
            {
                "PMID": "22258953", 
                "citation": "Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LW, Morris AD, Butler CC, Berger M, van der Wouden JC. Interventions for impetigo. Cochrane Database Syst Rev. 2012 Jan 18;1:CD003261. doi: 10.1002/14651858.CD003261.pub3. Review."
            }, 
            {
                "PMID": "19766888", 
                "citation": "Woodford N, Livermore DM. Infections caused by Gram-positive bacteria: a review of the global challenge. J Infect. 2009 Sep;59 Suppl 1:S4-16. doi: 10.1016/S0163-4453(09)60003-7. Review."
            }, 
            {
                "PMID": "18325835", 
                "citation": "Witte W, Cuny C, Klare I, N\u00fcbel U, Strommenger B, Werner G. Emergence and spread of antibiotic-resistant Gram-positive bacterial pathogens. Int J Med Microbiol. 2008 Jul;298(5-6):365-77. doi: 10.1016/j.ijmm.2007.10.005. Epub 2008 Mar 5. Review."
            }, 
            {
                "PMID": "12562687", 
                "citation": "Martin KW, Ernst E. Herbal medicines for treatment of bacterial infections: a review of controlled clinical trials. J Antimicrob Chemother. 2003 Feb;51(2):241-6. Review."
            }, 
            {
                "PMID": "12851592", 
                "citation": "Pieper B, Caliri MH. Nontraditional wound care: A review of the evidence for the use of sugar, papaya/papain, and fatty acids. J Wound Ostomy Continence Nurs. 2003 Jul;30(4):175-83. Review."
            }, 
            {
                "PMID": "10786448", 
                "citation": "Hewitt H, Whittle S, Lopez S, Bailey E, Weaver S. Topical use of papaya in chronic skin ulcer therapy in Jamaica. West Indian Med J. 2000 Mar;49(1):32-3."
            }, 
            {
                "PMID": "18759075", 
                "citation": "Owoyele BV, Adebukola OM, Funmilayo AA, Soladoye AO. Anti-inflammatory activities of ethanolic extract of Carica papaya leaves. Inflammopharmacology. 2008 Aug;16(4):168-73. doi: 10.1007/s10787-008-7008-0."
            }, 
            {
                "PMID": "15040064", 
                "citation": "Dawkins G, Hewitt H, Wint Y, Obiefuna PC, Wint B. Antibacterial effects of Carica papaya fruit on common wound organisms. West Indian Med J. 2003 Dec;52(4):290-2."
            }, 
            {
                "PMID": "9252760", 
                "citation": "Iliev D, Elsner P. Generalized drug reaction due to papaya juice in throat lozenges. Dermatology. 1997;194(4):364-6."
            }, 
            {
                "PMID": "8360400", 
                "citation": "Niinim\u00e4ki A, Reijula K, Piril\u00e4 T, Koistinen AM. Papain-induced allergic rhinoconjunctivitis in a cosmetologist. J Allergy Clin Immunol. 1993 Sep;92(3):492-3."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01943136"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Philippine Dermatological Society", 
            "investigator_full_name": "Pearl Weena Marie Sabido", 
            "investigator_title": "Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "time to clinical clearance", 
                "safety_issue": "No", 
                "time_frame": "1 week"
            }, 
            {
                "description": "The 6-point grading system will assess clinical response based on each of the following six paramaters. One point will be assigned for each of the following parameters present in a patient, with the maximum possible score on this grading system being 6. A patient need not satisfy all six parameters. A decrease in score on this grading system compared to baseline will indicate clinical improvement, while an increase in score will indicate clinical worsening.\nerythema\nedema\nvesiculation\npustulation\ncrusting\nscaling", 
                "measure": "score in the 6-point grading system", 
                "safety_issue": "No", 
                "time_frame": "1 week"
            }, 
            {
                "measure": "change in size of lesion compared to baseline", 
                "safety_issue": "No", 
                "time_frame": "1 week"
            }, 
            {
                "measure": "presence or absence of recurrence on any part of the body 2 weeks after starting treatment", 
                "safety_issue": "No", 
                "time_frame": "1 week"
            }, 
            {
                "measure": "presence or absence of adverse events during treatment", 
                "safety_issue": "Yes", 
                "time_frame": "1 week"
            }
        ], 
        "source": "Philippine Dermatological Society", 
        "sponsors": {
            "collaborator": {
                "agency": "St. Luke's Medical Center", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Philippine Dermatological Society", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}